INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 57 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $359,000 | -73.4% | 316,146 | -47.3% | 0.00% | -50.0% |
| Q4 2021 | $1,349,000 | +2308.9% | 600,239 | +3597.0% | 0.00% | – |
| Q3 2021 | $56,000 | -87.2% | 16,236 | -88.9% | 0.00% | -100.0% |
| Q2 2021 | $438,000 | -80.4% | 146,742 | -78.8% | 0.00% | -80.0% |
| Q1 2021 | $2,236,000 | +3094.3% | 691,892 | +1759.3% | 0.01% | – |
| Q1 2019 | $70,000 | +40.0% | 37,212 | -12.8% | 0.00% | -100.0% |
| Q4 2018 | $50,000 | -80.8% | 42,671 | -14.0% | 0.00% | -66.7% |
| Q1 2016 | $261,000 | +0.8% | 49,589 | +223.4% | 0.00% | 0.0% |
| Q4 2014 | $259,000 | -0.8% | 15,336 | -21.2% | 0.00% | -25.0% |
| Q3 2014 | $261,000 | – | 19,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
| Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
| QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
| BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
| Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
| Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
| Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
| OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
| Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |